CIK: 0001910264
Total reported value
$915.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ACLXGBX | Arcellx INC | Stock-Other | 39.54% | +7.77% | — | |
| 2 | SPRY | Ars Pharmaceuticals INC | Stock-Other | 12.97% | -3.10% | — | |
| 3 | MLYS | Mineralys Therapeutics INC | Stock-Other | 12.76% | -3.40% | +55.09% | |
| 4 | ZBIO | Zenas Biopharma INC | Stock-Other | 9.97% | -15.14% | — | |
| 5 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 9.17% | -4.55% | — | |
| 6 | DSGN | Design Therapeutics INC | Stock-Other | 6.47% | -1.08% | — | |
| 7 | ALMS | Alumis INC | Stock-Other | 3.09% | +2.01% | — | |
| 8 | OCS | Oculis Holding AG | Stock-Other | 1.58% | +0.05% | — | |
| 9 | NKTX | Nkarta INC | Stock-Other | 1.58% | -0.10% | — | |
| 10 | ORKA | Oruka Therapeutics INC | Stock-Other | 1.13% | +0.46% | — | |
| 11 | KALAEUR | Kala Bio INC | Stock-Other | 0.88% | — | — | |
| 12 | ✓ | Engene Holdings INC | Stock-Other | 0.86% | -0.40% | — |